Estrogen-Induced Sexual Incentive Motivation, Proceptivity and Receptivity Depend on a Functional Estrogen Receptor α in the Ventromedial Nucleus of the Hypothalamus but Not in the AmygdalaSpiteri T.a · Musatov S.b, c · Ogawa S.d · Ribeiro A.b · Pfaff D.W.b · Ågmo A.a
aDepartment of Psychology, University of Tromsø, Tromsø, Norway; bLaboratory of Neurobiology and Behavior, The Rockefeller University, New York, N.Y., and Neurologix Inc., Fort Lee, N.J., and cLaboratory of Molecular Neurosurgery, Weill Medical College of Cornell University, New York, N.Y., USA; dLaboratory of Behavioral Neuroendocrinology, University of Tsukuba, Tsukuba, Japan Corresponding Author
Department of Psychology, University of Tromsø
NO–9037 Tromsø (Norway)
Tel. +47 77 64 63 65, Fax +47 77 64 52 91
The display of copulatory behaviors usually requires the presence of a mate and is, therefore, preceded by a search for and approach to a potential partner. The intensity of approach behaviors is determined by a process labeled sexual incentive motivation. Although it is known that female sexual motivation depends on estrogens, their site of action within the brain is unknown. In the present experiment, we obtained data relevant to this issue. An shRNA encoded within an adeno-associated viral (AAV) vector directed against the estrogen receptor α (ERα) gene (or containing a nonsense base sequence as a control treatment) was injected bilaterally into the ventromedial nucleus of the hypothalamus (VMN) or the posterodorsal amygdala (MePDA) of female rats. After an 80% reduction of the number of ERα in the VMN, sexual incentive motivation was absent after treatment with estradiol and progesterone. Proceptivity and receptivity were also much reduced, while the number of rejections was enhanced. Suppression of the ERα in the MePDA lacked these effects. Likewise, the inactive control AAV vector failed to modify any behavior. Thus, the ERα in the VMN, but not in the MePDA, is important for proceptivity and receptivity as well as for sexual incentive motivation. These results show that ERα in the VMN is crucial for the entire sequence of behavioral events from the processes leading to the establishment of sexual contact until the accomplishment of copulatory behaviors.
© 2009 S. Karger AG, Basel
Female rodent reproductive behaviors are strictly dependent on ovarian hormones acting within the central nervous system [reviewed in ]. Studies of mice lacking either a functional estrogen receptor α (ERα) or estrogen receptor β (ERβ) gene have established that the ERα but not the ERβ is necessary for the activation of these behaviors by estrogens [2,3,4]. Likewise, systemic administration of the selective ERα agonist propyl-pyrazole triol to ovariectomized female rats activates receptivity and proceptivity, while the ERβ agonist diarylpropionitrile is ineffective . Moreover, it is known that a crucial site of action of estrogens is the ventromedial nucleus of the hypothalamus (VMN) [for reviews, see [6,7]]. Additional evidence for this was provided in a recent study where it was shown that infusion of a shRNA encoded within an adeno-associated viral (AAV) vector directed against the ERα gene into the VMN strongly reduced sexual receptivity and proceptive behaviors in female mice .
Displays of receptivity and proceptivity occur when the female is in close physical proximity to the male. In fact, lordosis is a tactile reflex  and proceptive behaviors are strongly stimulated by tactile stimuli provided by the male [reviewed in [10,11]]. Consequently, few or none of the copulatory behaviors are displayed at a distance from the male. Approach to a male is, then, an event normally preceding displays of copulatory behaviors . There are many observations suggesting that sexual approach behaviors are controlled differently from receptivity and proceptivity. Lesion studies have revealed that receptivity can be abolished without affecting approach to a sexually active male  while approach can be affected without reducing receptivity . Some lesions may even enhance receptivity while reducing sexual approach . Thus, the fact that the brain structures and the ER subtype involved in receptivity and proceptivity are quite well known does not mean that this applies to sexual approach behaviors. Furthermore, much of the recent data stem from studies in mice, and it is not evident that the hormone dependence of sexual approach behaviors is identical in rats and mice. In rats, approach to sexually relevant stimuli emitted by an intact male varies during the estrous cycle, with a peak around proestrus [16,17]. No such variation occurs in mice . There are even data suggesting that the approach of female mice to stimuli emitted by males is entirely independent of ovarian hormones . These observations indicate that it may be risky to extrapolate the results from mice to rats.
Although the brain areas involved in the control of receptivity and proceptivity as well as the crucial ER are reasonably well known, knowledge concerning sexual approach behaviors is scant. However, data from lesion studies [20,21] suggest that the VMN may be important for these behaviors, in addition to receptivity/proceptivity as mentioned above. However, lesion data do not allow for any conclusion as to the role of ERs, and even less as to the specific ER involved. Another potentially important structure for sexual approach is the amygdala. This structure receives projections both from the main and accessory olfactory systems, and olfactory stimuli are crucial for the activation of approach behaviors [reviewed in ]. Lesion of the medial posterodorsal amygdala (MePDA) reduces these behaviors in female rats [23,24]. Furthermore, there is a substantial projection from the amygdala to the VMN , suggesting that olfactory stimulation reaches the VMN via the amygdala. Thus, among all brain areas potentially involved in sexual approach behaviors, the case for a role of the VMN and the MePDA seems particularly strong.
In the present experiments we suppressed the ERα in the VMN and in the MePDA in ovariectomized femalerats with the help of a shRNA directed against the ERα receptor gene . Receptivity, proceptivity and sexual incentive motivation after treatment with estradiol and progesterone were then evaluated. These experiments provide data essential for our understanding of the hormonal control of sexual approach behaviors in addition to extending earlier observations on receptivity and proceptivity in the female mouse to the rat.
Male and female Wistar rats were obtained from Charles River WIGA (Sulzfeld, Germany). They were housed 2 per cage under a reversed light-dark cycle (12:12 h, lights off 11:00 h). Food (RM1, Special Diets Services, Witham, Essex, UK) and tap water were always available. Ambient temperature was maintained at 21 ± 1°C and relative humidity was 55 ± 10%. All females (250 g upon arrival to the animal facilities) were ovariectomized and some males (300 g upon arrival) were castrated under isofluorane anesthesia. All experimental procedures employed in the present experiment were approved by the National Animal Research Authority of Norway and were in agreement with the European Union council directive 86/609/EEC.
About 2 weeks after ovariectomy, some females received intracerebral infusions of either a shRNA encoded within an AAV vector directed against the ERα gene (ERα shRNA) or with a shRNA containing a nonsense base sequence (AAV control) as well as an independent EGFP (enhanced green fluorescent protein) expression cassette to detect neurons transduced by our viral vector. Hence, EGFP is used as a marker of correct injection localization. The vector AAV control was designed to suppress luciferase expression. The shRNAs employed here have been described in detail elsewhere . Before infusion, the females were fixed in a stereotaxic frame under ketamine/xylazine anesthesia (100 and 10 mg/kg, respectively). The skull was exposed, and small holes were drilled at the appropriate places after removal of the fascia. Bilateral cannulae (30 gauge) were aimed at the VMN (coordinates were: anteroposterior –2.80; mediolateral ±0.6; dorsoventral –9.6; n =13 for ERα shRNA as well as for AAV control), the MePDA (coordinates: anteroposterior –3.14; mediolateral ±3.6; dorsoventral –8.2; n = 13 for ERα shRNA as well as for AAV control) or the cerebral cortex dorsal to the VMN (coordinates: anteroposterior –2.80; mediolateral ±0.6; dorsoventral –2; n = 13). Coordinates were based on the Paxinos and Watson (1998) atlas. 1 µl of PBS solution containing 109 packaged genomic particles of one of the viral vectors was injected on each side over a 10-min period using a 10-µl Hamilton syringe attached to a microinfusion pump. The cannulae were slowly withdrawn 5 min after the end of infusion.
Tests were performed 3–4 weeks after intracerebral infusion. Experimental females were given estradiol benzoate (18 µg/kg) about 52 h before behavioral testing was begun. Progesterone (1 mg/rat) was injected 48 h after estradiol and 4 h before the beginning of behavioral tests. Both steroids were purchased from Sigma (St. Louis, Mo., USA), and injected subcutaneously in 1 ml/kg and 0.2 ml/rat of peanut oil, respectively. These doses of the ovarian hormones have previously been reported to produce a lordosis quotient (LQ) close to 100 and a sexual incentive motivation of the same magnitude as that observed at proestrus/estrus in intact, cycling rats [10,17].
This testhas been described in detail elsewhere . Briefly, an oval open field is surrounded by a 45-cm-high wall in which there are two diagonally opposed openings (25 × 25 cm) at floor level. Outside these openings, incentive animal cages (25 × 15 × 25 cm high) can be fitted. These cages have a double wire mesh front (openings 12 × 12 mm, distance between the meshes about 10 mm) connecting to the observation arena. Within the arena and outside each incentive cage a virtual zone (30 × 21 cm) is defined. A video tracking system (Ethovision Pro, Noldus, Wageningen, The Netherlands) determines the experimental subject’s position online. An incandescent light bulb provides a white light intensity of about 5 lx in the arena. Before every experimental session, the arena is cleaned with a 0.1% solution of glacial acetic acid in water. No cleaning is made between subjects within a session. This is the standard procedure used in the laboratory [26,27].
The incentives employed were an intact and a castrated male. The same incentive animals were used for all females. At tests, the experimental subject was introduced into the middle of the arena. Immediately thereafter, the experimenter left the room and did not return until just after the end of the 10-min observation period. The subject was then gently removed from the arena, and the following rat was immediately introduced. The position of the incentive animals was semirandomly changed during the experimental session. Spatial location was, therefore, a useless predictor of the endocrine state of the incentives.
The time the experimental subject spent in each incentive zone, the number of visits to the zones, the total distance moved during the test, and the mean velocity while moving were determined. In addition, a preference score (time spent in the intact male zone/time spent in both incentive zones) was calculated.
All females had been familiarized to the apparatus at three sessions of 10 min each performed about 1 week before the experimental test. No ovarian hormones were administered before the familiarization sessions.
Sexually naive females were employed. It has been demonstrated that sexual experience does not modify sexual incentive motivation in female rats [28,29]. Furthermore, male odor is an unconditioned incentive for females .
This test was performed just after the unconditioned sexual incentive motivation test, but in another room. The experimental female was introduced into a rectangular observation cage (40 × 60 × 40 cm high) with a Plexiglas front where a sexually experienced male was waiting. The test lasted until the female had received 10 mounts with pelvic thrusting. The presence or absence of lordosis in response to each mount was recorded. Receptivity was quantified as the LQ (the number of lordosis displayed divided by the number of mounts received multiplied by 100). Proceptive behaviors (hop-darting and ear-wiggling) as well as rejections (kicking, boxing, fleeing) were also recorded.
The day following the behavioral tests the subjects were euthanized with carbon dioxide. Females were perfused with PBS followed by 4% paraformaldehyde. The brain was removed and postfixed overnight at 4°C in 4% paraformaldehyde. It was then rinsed with PBS and cryoprotected in 30% sucrose in PBS. After 24 h in the sucrose solution, the brain was frozen in isopentane cooled on dry ice, and then transferred to a –80°C freezer for storage until processing.
Brains were frozen-sectioned at 50 µm with a microtome. According to injection localization, alternate sections containing the VMN or the MePDA were collected and processed according to a conventional free-floating protocol. Antibodies against the ERα (polyclonal, 1:25,000; Upstate, Lake Placid, N.Y., USA) and EGFP (GFP, Abcam, Cambridge, Mass., USA) were used in combination with secondary antibodies (biotinylated rabbit) and avidin-biotin peroxidase complex (ABC Elite Kit from Jackson Immunoresearch, West Grove, Pa., USA) to identify cells containing ERα and transduced cells, respectively. After antibody reactions, sections were stained with diaminobenzidine. This staining gave a brown coloration to EGFP. Hence, neurons transduced with our virus were labeled by brown cytoplasmic staining. In contrast, this staining colored the ERα in purple. Thus, brown-stained cells indicated injection localization while purple-stained cell showed ERα expression.
For comparisons between experimental and control groups, the number of ERα-stained cells in the VMN and the MePDA was determined. For this, photographs of each nucleus were taken by a combination of microscope (Nikon Eclipse E400) and camera (Nikon CoolPix 990). Then, pictures were transferred to a computer and opened by Photoshop software. By a virtual pen, zones were drawn over the VMN and the MePDA and the stained cells within were counted. The number of ERα was divided by the surface of each nucleus in order to obtain a density (number of ERα/mm2). In order to determine the spread of ERα knockdown, ERα-stained cells were also counted in structures adjacent to the injection sites, the arcuate nucleus for the VMN and the posteroventral amygdala for the MePDA.
Five groups of 13 rats each were used: (1) ERα shRNA infused into the MePDA; (2) AAV control infused into the MePDA; (3) ERα shRNA infused into the VMN; (4) AAV control infused into the VMN, and (5) ERα shRNA infused into the cerebral cortex.
Only rats with successful and effective bilateral virus infusion at the intended site (the VMN or the MePDA) were included in the analyses. In these animals, the number of ERα-immunoreactive cells in the groups treated with ERα shRNA in the VMN and in the cerebral cortex and those treated with AAV control in the VMN was evaluated with one-factor ANOVA. A t test was performed for the groups infused with ERα shRNA and AAV control in the MePDA.
Behavioral data from the three groups infused with ERα shRNA and AAV control into the VMN as well as the group infused with ERα shRNA into the cerebral cortex above the VMN were analyzed separately from the groups infused with ERα shRNA and AAV control in the MePDA. In the first case, sexual incentive motivation data were analyzed with one-factor ANOVA (preference score, distance moved, velocity of movement, time moving) or with two-factor ANOVA for repeated measures on one factor (time spent in the incentive zones). The between-groups factor was treatment (ERα shRNA in the VMN, ERα shRNA in the cerebral cortex, AAV control in the VMN), while the within-groups factor was incentive (intact male vs. castrated male). In case of non-homogenous error variances, as determined by Levene’s test, data were subjected to a logarithmic transformation. Following significant ANOVA, Tukey’s HSD test was employed for determining group differences. In case of significant interaction, tests for simple main effects within treatments as well as within incentives were performed. The preference score was also compared to no preference (i.e., a score of 0.5) with a t test in each group. Data from the test for copulatory behavior were analyzed with Kruskal-Wallis non-parametric ANOVA followed by Nemenyi’s test [31 ]in case of significance.
Sexual incentive motivation data from the MePDA groups were analyzed with t test or with two-factor ANOVAs when appropriate. Copulatory behaviors were evaluated with the Mann-Whitney U test. Relationships between parameters of copulatory behavior and sexual incentive motivation were evaluated with Spearman’s rank correlation. A two-tailed significance level of 0.05 was used in all analyses.
Of the 13 animals infused with the shRNA directed against the ERα gene into the VMN, 4 had cannulae tips outside this nucleus. Thus, 9 females remained in the ERα shRNA VMN group. The 4 animals with misplaced infusions were included in the cortex group, which thus ended up with an n = 17. There are 13 animals in each groups infused by AAV control into the VMN and the MePDA as well as the group infused by ERα shRNA into the MePDA.
As can be seen in figure 1a, the number of ERα was significantly reduced in animals infused with ERα shRNA into the VMN compared to animals infused into the cortex and those infused with AAV control, F(2,38) = 37.74, p < 0.001. The Tukey HSD test revealed that the group infused with ERα shRNA into the VMN had a lower number of ERα than the groups infused with AAV control into the VMN as well as the group infused with ERα shRNA into the cortex. In the same way, ERα were significantly fewer in animals infused with ERα shRNA than those infused with AAV control into the MePDA, t(24) = 9.479, p < 0.001. Indeed, there was a reduction of ERα expression of 80% in the VMN, and of 81% in the MePDA. It can also be seen that the suppression of ERα is site-specific. The ERα staining in the adjacent arcuate nucleus was unaffected by infusion of ERα shRNA or AAV control into the VMN as well as by ERα shRNA infusion into the cortex, F(2,38) = 0.957 (fig. 1b, 2). Likewise, the group infused with ERα shRNA into the MePDA presented low ERα staining there but not in the medial posteroventral amygdala, t(24) = 1.873, not significant (ns) (fig. 1b).
Sexual Incentive Motivation. No group differences in velocity, distance moved or time moving were found either between the VMN groups, F(2,38) = 1.396, ns, F(2,38) = 0.926, ns, and F(2,38) = 2.575, ns, respectively, or between the MePDA groups, t(24) = 0.638, ns, t(24) = 0.610, ns, and t(24) = 1.2, ns, respectively. Hence, these parameters are not further mentioned.
There was a significant main effect of treatment on the preference score, F(2,38) = 9.521, p < 0.001. The Tukey HSD test revealed that the group infused with AAV control into the VMN as well as the group infused with ERα shRNA into the cortex had a higher preference score than the group infused with ERα shRNA into the VMN. The preference score in the latter group was not different from 0.5 (no preference), t(8) = 0.773, ns, while the animals in the other two groups preferred the intact over the castrated male, t(12) = 6.494, p < 0.001 for the group infused with AAV control into the VMN, and t(16) = 7.302, p < 0.001 for the group infused with ERα shRNA into the cortex.
Concerning the time spent in the incentive zones, there was a significant main effect on incentive, F(1,36) = 47.306, p < 0.001. The interaction treatment × incentive was also significant, F(2,36) = 8.509, p < 0.001. There was no effect of treatment, F(2,36) = 1.956, ns. Tests for simple main effects of incentive within treatment showed that the subjects treated with ERα shRNA into the VMN spent as much time in the castrated male’s incentive zone as they did in the intact male’s incentive zone, F(1,36) = 0.35, ns. At difference, animals infused with AAV control into the VMN or with ERα shRNA into the cortex spent more time in the intact male’s incentive zone, F(1,36) = 22.78, p < 0.001 and F(1,36) = 61.18, p < 0.001, respectively. When the effect of treatment within incentive was analyzed, it was found that there was no treatment effect on the time spent in the castrated male’s incentive zone, F(2,36) = 4.36, ns, while the groups differed with regard to the time spent in the intact male’s incentive zone, F(2,36) = 7.45, p < 0.01. Tukey’s HSD test showed that the group infused with ERα shRNA into the VMN spent less time in this zone than the group infused with ERα shRNA into the cortex.
Regarding the total time spent close to both incentive zones, females infused with ERα shRNA into the VMN spent 335 ± 12 s in the incentive zones, while females infused with AAV control into the VMN or with ERα shRNA into the cortex spent 349 ± 10 and 374 ± 15 s, respectively. These differences are not significant, F(2,36) = 1.956, ns. Data are illustrated in figure 3a and b.
Copulatory Behavior. The LQ differed between the three VMN groups, H = 17.985, p < 0.001. The Nemenyi’s test showed that the group infused with ERα shRNA had a lower LQ than the other groups (fig. 4a). Similar effects were obtained with regard to proceptive behaviors, H = 19.180, p < 0.001 (fig. 4b). The number of rejections showed an inverse pattern, with a large number in the group infused with ERα shRNA and a low number in the other groups, H = 19.180, p < 0.01 (fig. 4c).
Sexual Incentive Motivation
The shRNA had no effect on preference score (all comparisons between the ERα shRNA and AAV control groups had p > 0.065). Both groups preferred the intact over the castrated male, and spent more time with the intact male (all p < 0.01).
Females infused with ERα shRNA into the MePDA spent 310 ± 18 s in both incentive zones, while females infused with AAV control into the MePDA spent 373 ± 16 s. This difference is significant, t(24) = 2.533, p < 0.05. However, considering the incentive zones separately, females infused with ERα shRNA into the MePDA did not spend less time close to the castrate male than those infused with AAV control into the MePDA did, t(24) = 1.143, ns. This is also the case for the time spent close to the intact male, t(24) = 1.291, ns. Data are summarized in figure 3a and b.
Although females in the group infused with ERα shRNA into the MePDA had a substantial reduction of the number of ERα in this structure, neither LQ nor proceptive behaviors or rejections were affected (all p > 0.545; fig. 4a–c).
As expected, there was a strong parallelism between results from the sexual incentive motivation test and those from the copulatory behavior test. Female rats displaying receptivity and proceptivity showed also normal sexual incentive motivation. There were positive correlations between LQ, ρ = 0.400, p < 0.05, as well as between proceptive behaviors, ρ = 0.428, p < 0.01, and preference score. Likewise, the reduction of lordosis and proceptive behaviors due to silencing of ERα expression in the VMN was accompanied by rejection and absence of sexual incentive motivation. Indeed, rejection was negatively correlated with preference score, ρ = –0.407, p < 0.05, LQ, ρ = –0.728, p < 0.01, and proceptive behaviors, ρ = –0.705, p < 0.01. These results reinforce the notion that sexual incentive motivation and copulatory behavior are equally determined by the ERα.
The RNAi employed in the experiments reported herein turned out to be a most efficient tool for drastically reducing the amount of immunoreactive ERα in a small area around the infusion sites while leaving this receptor unaffected in adjacent structures. It is also noteworthy that an infusion into the cerebral cortex, placed exactly above the VMN, failed to affect ERα expression in the VMN or the MePDA. It may be important to mention that the shRNA employed here does not affect the ERβ . It is, consequently, not unreasonable to propose that all effects observed after infusion into the VMN or the MePDA are a result of a reduced number of ERα in these specific structures.
An 80% reduction of the ERα in the VMN abolished sexual incentive motivation, expressed as approach to a potential mate, in the female rat. A similar effect has been reported after partial or complete lesion of the VMN [20,21]. Present results show that estrogen actions on the ERα within the VMN are necessary for the activation of sexual approach behaviors in response to stimuli emitted by an intact male. An important issue is whether such actions also are sufficient for the display of sexual approach. Present data do not allow for any conclusion about this. It could also be maintained that the reduction of ERα in either brain structure disrupted attraction to conspecific males regardless of their reproductive status. ERα knockdown in the VMN did not reduce the total time spent in the incentive zones, making such a proposal unlikely. However, the reduction of the ERα in the MePDA provided less clear results. While the preference for the intact male was not reduced, the total time spent in the incentive zones was. Since both the intact and castrated males have social incentive properties, the intact male having sexual incentive properties in addition, this could indicate that a reduction of ERα in the MePDA reduces social motivation. This proposal is somewhat weakened by the fact that neither the time spent in the intact male incentive zone nor that spent in the castrated male’s incentive zone was reduced when analyzed separately.
Another issue is whether the shRNA directed against the ERα impaired olfactory discrimination after infusion into the VMN. If the females could not distinguish between olfactory cues emitted by the intact male from those emitted by the castrated male, they could obviously not show any preference for the intact male. There are, indeed, some data suggesting that estrogens enhance odor detection capacity in mice . However, differences between untreated ovariectomized and estrogen-treated females become evident only after a substantial dilution of male urine. In rats, ovariectomy improves detection of volatile odors [33,34]. These data suggest that absence of estrogens does not impede the females from distinguishing an intact from a castrated male. Consequently, it is unlikely that the absence of sexual incentive motivation in the females with a reduced number of ERα in the VMN can be attributed to olfactory deficits.
Sexual approach behaviors are activated by olfactory stimuli, since bedding soiled by an intact male or urine from such males are approached more than bedding soiled by a castrated male or another female or urine from these animals [35,36,37] even if direct physical contact with the olfactory stimulus is impossible [36,38,39,40]. Olfactory stimuli are, then, sufficient for inducing sexual approach in female rats since they do so in the absence of other kinds of stimuli. They are also necessary, since section of the olfactory nerves (without causing damage to the olfactory bulbs) eliminates approach behaviors . The chemical stimulus passes from the olfactory epithelium to the main olfactory bulb and from there to the amygdala. Intrinsic connections in the amygdala allow the stimulus to access the MePDA . Finally, the MePDA projects to the VMN and preoptic area, mainly through the stria terminalis . ERs have been reported to be present in olfactory epithelial tissue , primary olfactory neurons , main and accessory olfactory bulbs and in the amygdala [45,46,47]. It is not impossible that estrogen actions on ERα in several or some of these structures, in addition to actions within the VMN, are required for sexual approach behaviors. However, an 80% reduction of the number of ERα in the MePDA did not affect the intensity of approach behaviors suggesting that any possible estrogen actions in the MePDA are not necessary. If the ERα affects sensory systems in a way significant for approach, it must be either in the olfactory bulbs or in the nasal epithelium.
Efferent projections from the VMN to the midbrain follow medial and lateral routes terminating mainly in the dorsal and lateral part of the periaqueductal gray . Bilateral transection of lateral efferent fibers from VMN to midbrain disrupts sexual partner preference in female rats . This suggests that these axons from the VMN to the periaqueducal gray mediate estrogen action involved in sexual approach behaviors. Likewise, present results suggest that the crucial site of action for estradiol in controlling the intensity of sexual approach behaviors, frequently considered an expression of sexual incentive motivation, is localized to the VMN. Whether downstream ER-containing structures have any modulatory role in the control of sexual incentive motivation or not needs to be analyzed in future studies.
A reduction of the number of ERα in the VMN also reduced the display of lordosis and proceptive behaviors. To the contrary, rejections are much enhanced in females with few ERα in that structure. These results coincide with data from the mouse . Similar observations have earlier been made after different kinds of lesion of the VMN [50,51,52] or following implants of ER antagonists [53,54]. Since the implantation of minute amounts of estradiol into the VMN activates complete female copulatory behavior [55,56], it appears that the VMN is not only necessary but also sufficient for this behavior. Independently of this, it is conceivable that estrogen actions outside the VMN might modulate some aspects of female copulatory behavior.
One of the main efferent projections of the VMN is to the periaqueductal central gray , and lesion of this structure has been found to strongly reduce lordosis [e.g. [58,59]]. However, implants of estradiol within this structure are not able to activate lordosis unless the VMN is simultaneously exposed to estrogens . Nevertheless, estradiol affects neuronal firing within this structure  and could, consequently, modify the display of lordosis. The periaqueductal central gray also receives important projections from the lateral septum and the preoptic area , and is in an excellent position for integrating lordosis facilitating input from the VMN and inhibitory inputs from the preoptic area and lateral septum. Whether such an integration is modulated by the ERα or not remains unknown.
Destruction of the olfactory epithelium does not modify the expression of lordosis . To the contrary, lesions of the olfactory bulb have consistently been found to enhance lordosis in female rats [63,64,65,66], facilitate the display of proceptive behaviors , and probably reduce fear signals. ERs in the olfactory bulb could, in principle, be involved in these effects. Results from the present experiment do not allow for any conclusion as to the role of the ERα in the olfactory primary projection areas.
Lesion of the MePDA has been reported to enhance lordosis intensity and proceptive behaviors [68,69] while leaving pacing behavior unaffected . These data suggest that neurons in the MePDA may exert some inhibitory action on lordosis and proceptivity. The results of the present experiment suggest that any such effect is independent of the ERα, since animals with a much reduced number of these receptors in the MePDA did not have proceptive behaviors or lordosis different from controls.
One of the main cellular effects of estrogens is to enhance the number of progesterone receptors. There are data suggesting that this effect depends on the ERα . Consequently, it is possible that the number of available progesterone receptors was much reduced in the VMN and MePDA, respectively, after administration of the shRNA directed against the ERα. Since progesterone receptors were not counted, the magnitude of this reduction is unknown. Nevertheless, a lack of progesterone action could explain the absence of sexual incentive motivation in the group with reduced number of ERα in the VMN. In fact, ovariectomized females treated with estradiol alone fail to show any preference for an intact male . Likewise, receptivity is enhanced by progesterone in females treated with low doses of estradiol . Furthermore, proceptivity is progesterone-dependent unless very high doses of estradiol are administered . In principle, all the behavioral effects found in the present experiments could be attributed to reduced progesterone action. However, in the ERα knockout mouse, estradiol preserves the capacity to enhance progesterone receptor immunoreactivity in the VMN, albeit to a lower extent than in the wild type [74,75]. Despite the presence of estrogen-induced progesterone receptors, these mice show only marginal levels of female sexual behaviors . This fact suggests that additional factors, besides progesterone receptor availability, are involved in the reduction of sex behaviors in these mice. Furthermore, even if a decrease in progesterone receptor induction were involved in the effects found in the present experiment, the fact that sexual incentive motivation and copulatory behaviors are strongly reduced in females with a reduced number of ERα in the VMN is not altered.
The results obtained in the experiment reported here demonstrate that the ERα in the VMN is crucial for the entire sequence of behavioral events from the processes leading to the establishment of sexual contact until the accomplishment of copulatory behaviors. This constitutes strong evidence for the assertion that the ERα in the VMN is necessary for all aspects of female rat sexual behavior. We even speculate that estrogen action in VMN may be sufficient for these behaviors. It seems, then, that the VMN somehow determines if sensory input, be it tactile or olfactory, should be relayed to motor systems or not. In the presence of an activated ERα, the likelihood for connecting the sensory and motor systems is high, while it is low or entirely absent when the ERα is not activated. The notion of the VMN as a central actor in the control of female sexual behaviors was eloquently elaborated long ago [6,7], but here we offer additional support and provide data as to the ER involved. Present results also show that the ERα in the MePDA does not influence female sexual behaviors to any significant degree. Further studies selectively manipulating the ERα in several parts of the olfactory pathway, the preoptic area and the septum as well as the periaqueductal gray and other projection areas of the VMN are necessary before we can achieve a complete picture of estrogen activation of female sexual behaviors. Such studies are perfectly feasible, and it is to be hoped that we soon will have a detailed understanding of the neural circuits, and the actions of estrogens thereupon, responsible for all aspects of female sexual behavior.
Expert technical assistance was provided by Ragnhild Osnes, Stig Rune Olsen, Carina Sørensen and Nina Løvhaug. Financial support was received from the University of Tromsø (to T.S. and A.Å.) and from grants MH 38273 and HD 05751 to D.W.P.
Department of Psychology, University of Tromsø
NO–9037 Tromsø (Norway)
Tel. +47 77 64 63 65, Fax +47 77 64 52 91
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.